Search

everythinglearnresearchcommunity

for

Search:↓

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

ERG increases SOX9, promoting prostate cancer growth and invasion.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Anabolic steroid users may face higher risk of severe COVID-19.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Testosterone may influence COVID-19 severity and outcomes.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Possible link between androgens and COVID-19 severity; more research needed.

Key genes can rewire networks, changing skin appendage types.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Iron deficiency in menstruating women causes many health issues beyond anemia and needs early detection and treatment.

Iron deficiency is the main cause of hair loss in women, and iron supplements started within 6 months can improve hair health.

Macrophage iron release is crucial for hair growth and wound healing.

Some vitamins and minerals like vitamin D and iron can help with certain types of hair loss, but more research is needed for others.

Sex hormones may affect COVID-19 severity and outcomes.